Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

OBJECTIVE: Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. METHODS: These questions were investigated in a case–control st...

詳細記述

保存先:
書誌詳細
主要な著者: Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K. V., Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., Hoque, Ashraful
フォーマット: Artigo
言語:Inglês
出版事項: Springer Netherlands 2011
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139891/
https://ncbi.nlm.nih.gov/pubmed/21667068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-011-9787-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料